CUSIP 40637H109COMHALOQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
604 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 13.15M | $885.25M | +293.7K | Added |
| 2 | Vanguard Group Inc | 11.57M | $778.45M | −62.9K | Reduced |
| 3 | State Street Corp | 5.12M | $344.69M | +102.5K | Added |
| 4 | Invesco Ltd. | 3.65M | $245.51M |
| Added |
| 5 | Arrowstreet Capital, Limited Partnership | 3.22M | $216.87M | −68.2K | Reduced |
| 6 | Bank Of America Corp /De/ | 2.73M | $183.99M | +757.6K | Added |
| 7 | Morgan Stanley | 2.66M | $178.90M | +920.7K | Added |
| 8 | Geode Capital Management, LLC | 2.43M | $163.78M | +1.9K | Added |
| 9 | Snyder Capital Management L P | 2.40M | $161.47M | −334.7K | Reduced |
| 10 | Dimensional Fund Advisors LP | 2.10M | $141.61M | +25.7K | Added |
See every fund holding Halozyme Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders